Announcement on Amendments to the Report on Issuance of Shares and Payment of Cash to Purchase Assets and Raise Supporting Funds and Related Party Transactions (Draft) (Review Draft)

Maple Medical Co., Ltd.·June 17, 2026·2 pages

✨ AI Summary

This announcement details amendments to a report concerning Guangzhou Medprin Biomedical Technology Co., Ltd.'s acquisition of 100% equity in Guangzhou Med-In Medical Technology Co., Ltd. through share issuance and cash payment. The amendments address risks related to performance commitments, compensation, integration, and market competition, following a review by the Shenzhen Stock Exchange.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Guangzhou Medprin Biomedical Technology Co., Ltd.

Announcement on Amendments to the Report on Issuance of Shares and Payment of Cash to Purchase Assets and Raise Supporting Funds and Related Party Transactions (Draft) (Review Draft)

The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed herein, and are free from any false representations, misleading statements, or material omissions.

Guangzhou Medprin Biomedical Technology Co., Ltd. (hereinafter referred to as the "Listed Company" or the "Company") intends to acquire 100% equity of Guangzhou Med-In Medical Technology Co., Ltd. (hereinafter referred to as the "Target Company" or "Med-In Medical") held by Guangzhou Zexin Medical Technology Co., Ltd., Guangzhou Yichuang Investment Partnership (Limited Partnership), and 9 other counterparties, by issuing shares and paying cash, and to raise supporting funds (hereinafter referred to as the "Transaction").

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.